Defining normal serum creatinine in pregnancy—results from the AKID UK prospective cohort study
Clinical Kidney Journal · 03.02.2025 · 18 (2)
DOI: 10.1093/ckj/sfae418 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Kidney Journal, online erschienen am 18.12.2024. Verfasst von Laura Skinner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Richard Bright Renal Service, North Bristol NHS Trust, Bristol, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Background
Abnormal kidney function in pregnancy may represent chronic kidney disease or pregnancy-associated acute kidney injury, both associated with adverse outcomes during and after pregnancy. Serum creatinine remains the standard biomarker for kidney function in pregnancy, but normal levels change dynamically through pregnancy and at term. Existing gestation-specific reference ranges for serum creatinine and recommendations to investigate for abnormal kidney function in pregnancy are based on limited data. Data describing trajectories of serum creatinine through pregnancy and the normal, physiological increase in serum creatinine at term are also lacking.
Methods
We recruited 476 healthy pregnant individuals aged 16 years or over, 2019–21, measuring serum creatinine in the first, second and third trimesters of pregnancy, at birth and postpartum. Clinical data were abstracted. Gestation-specific reference ranges for serum creatinine were defined as mean ± 1.96 × SD, after excluding those with adverse pregnancy outcomes. Trajectories of serum creatinine through pregnancy, and the change in serum creatinine at delivery were described.
Results
1875 creatinine measurements were recorded. Reference ranges for serum creatinine in the first, second and third trimesters of healthy pregnancy were 37–67 μmol/l (0.42–0.75 mg/dl), 34–63 μmol/l (0.38–0.71 mg/dl), and 34–66 μmol/l (0.39–0.75 mg/dl). Increasing serum creatinine in early pregnancy was more common in those with hypertensive disorders of pregnancy, prior to disease onset. In healthy participants, median serum creatinine increase from 36 weeks to birth was 6.8% (95% CI 4.5%, 9.1%).
Conclusions
Investigation for abnormal kidney function in pregnancy should be considered at a lower creatinine threshold than currently recommended. Detecting abnormal creatinine trajectories may help early identification of high-risk pregnancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Richard Bright Renal Service, North Bristol NHS Trust, Bristol, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.
ORCID-Profile: Abigail Fraser, Dominic M Taylor
Förderung
- British Heart Foundation
Zitieren
APA
Skinner, L., Birnie, K., Mettam, K. A., Standing, J. P., Howell, A. E., Lenguerrand, E., Fraser, A., Armitage, A. J., Burden, C., & Taylor, D. M. (2025). Defining normal serum creatinine in pregnancy—results from the AKID UK prospective cohort study. Clinical Kidney Journal, 18(2). https://doi.org/10.1093/ckj/sfae418
Vancouver
Skinner L, Birnie K, Mettam KA, Standing JP, Howell AE, Lenguerrand E, et al. Defining normal serum creatinine in pregnancy—results from the AKID UK prospective cohort study. Clinical Kidney Journal. 2025;18(2). doi:10.1093/ckj/sfae418
BibTeX
@article{Skinner2025,
author = {Skinner, Laura and Birnie, Kate and Mettam, Katie A and Standing, Judith P and Howell, Amy E and Lenguerrand, Erik and Fraser, Abigail and Armitage, Alison J and Burden, Christy and Taylor, Dominic M},
title = {Defining normal serum creatinine in pregnancy—results from the AKID UK prospective cohort study},
journal = {Clinical Kidney Journal},
year = {2025},
volume = {18},
number = {2},
doi = {10.1093/ckj/sfae418}
}
EUVIMED